CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy. - Ramírez-Fernández Á; Dimitri AJ; Chen F; Bartoszek R; Chen GM; Córdoba-Espejo L; Zhou Y; Tang YH; Lin CT; Acosta R; Scholler J; Ghilardi G; et al. (Nature biomedical engineering, 2025)